To cite this paper use one of the standards below:
Different pathogens activate mast cells to release DNA Extracellular Traps (DETs) composed of chromatin associated with granule proteins such as tryptase and LL-37. Activated mast cells also secrete pro-inflammatory cytokines and can induce vascular permeability, facilitating inflammation. This study hypothesizes that mast cell DETs induced by SARS-CoV-2 and its Spike protein are associated with the pathophysiology of COVID-19 and these DETs contribute to cellular damage. In the present work, we evaluated whether SARS-CoV-2 and its Spike protein could induce DETs release by mast cells. The human mast cell line HMC-1 was stimulated with different SARS-CoV-2 MOIs and/or Spike protein concentrations (µg/mL) for 4 hours, and DETs were quantified using Picogreen and visualized by fluorescent microscopy. Statistical analyses were performed with GraphPad Prism 8.0.1 software. Our results showed DET production by HMC-1 at all different virus MOIs and at all Spike concentrations. We evaluated the signaling pathways involved in DET production, such as ROS, calcium, and serine protease activity, by pre-treating HMC-1 with inhibitors (NAC, DPI, BAPTA, and Nafamostat) prior to incubation with SARS-CoV-2 and/or Spike. DET production was measured after 4 hours. Our results showed that all inhibitors significantly reduced DET production, suggesting that DET release was dependent on ROS, calcium, and serine protease activity. We also evaluated the toxicity of DETs to A549 and Calu-3 lung cell lines by treating these cells with different concentrations of virus and Spike DETs (50, 100, 200, and 400 ng/mL) for 24 hours and measuring LDH release. We observed significant cell death in both cell lines treated with DETs, as indicated by LDH release. Our findings reveal that SARS-CoV-2 and Spike protein induces DET production by mast cells dependent on ROS, calcium, and serine protease activity, and these DETs are toxic to lung cells, possibly contributing to COVID-19 pathology.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper